# Efficacy of Bromopride and Simethicone Versus Bromopride in Functional Dyspepsia

> **NCT02604576** · PHASE3 · COMPLETED · sponsor: **EMS** · enrollment: 339 (actual)

## Conditions studied

- Dyspepsia

## Interventions

- **DRUG:** FDC Bromopride 10 mg and Simethicone 80 mg
- **DRUG:** Bromopride 10 mg

## Key facts

- **NCT ID:** NCT02604576
- **Lead sponsor:** EMS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-17
- **Primary completion:** 2018-03-13
- **Final completion:** 2019-03-11
- **Target enrollment:** 339 (ACTUAL)
- **Last updated:** 2021-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02604576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02604576, "Efficacy of Bromopride and Simethicone Versus Bromopride in Functional Dyspepsia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02604576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*